mTOR inhibitors in polycystic kidney disease
- PMID: 20581393
- DOI: 10.1056/NEJMe1006925
mTOR inhibitors in polycystic kidney disease
Comment on
-
Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.N Engl J Med. 2010 Aug 26;363(9):820-9. doi: 10.1056/NEJMoa0907419. Epub 2010 Jun 26. N Engl J Med. 2010. PMID: 20581391 Clinical Trial.
-
Everolimus in patients with autosomal dominant polycystic kidney disease.N Engl J Med. 2010 Aug 26;363(9):830-40. doi: 10.1056/NEJMoa1003491. Epub 2010 Jun 26. N Engl J Med. 2010. PMID: 20581392 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous